Patent 5166202 Issued on November 24, 1992. Estimated Expiration Date: December 13, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/220, Tricyclo ring system having the seven-membered hetero ring as one of the cyclos514/219Polycyclo ring system having the seven-membered hetero ring as one of the cyclos
Midazolam and its pharmaceutically acceptable salts are useful in the treatment of panic disorder, panic attacks and the prevention of panic attacks.
Other References
Ballenger, J. C. et al., "Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment," Arch Gen Psychiatry, 45:413-422 (1988)
Wheeler, E. O., et al., "Neurocirculatory asthenia: a 20-year follow-up study of 173 patients," JAMA, 142:878-889 (1950)
Breier A. et al., "Agoraphobia with panic attacks: development, diagnostic stability, and course of illness," Arch Gen. Psychiatry, 43:1029-1036 (1986)
Noyes, R. et al., "Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study," J. Clin. Psychiatry, 50163-169 (1989)
Nagy, L. M. et al., "Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder," Arch Gen Psychiatry, 46:993-999 (1989)
Noyes, R. et al., "Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants," J. Affective Disord, 16:249-257 (1989)
Mavissakalian, M. et al., "Imipramine in the treatment of agoraphobia: dose-response relationships," Am J. Psychiatry, 142:1032-1036 (1985)
Rickels, K. et al., "Chronic therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation," Arch Gen Psychiatry (in press)
Schweizer, E. et al., "Chronic therapeutic use of benzodiazepines: II. Effects of gradual taper," Arch Gen. Psychiatry (in press)
Roy-Byrne, P. P. et al., "Benzodiazepine withdrawal: overview and implications for the treatment of anxiety." Am J. Med., 84:1041-1052 (1988)
Reves, J. G. et al., "Midazolam" pharmacology and uses, Anesthesiology, 62:310-324 (1985)
Dundee, J. W. et al., "Midazolam" a review of its pharmacological properties and therapeutic use, Drugs, 28:519-541 (1984)
Forrest, P. et al., "Placebo controlled comparison of midazolam, triazolam and diazepam as oral premedicants for outpatient anaesthesia," Anaesth Intens Care, 15:296-304 (1987)
O'Boyle, C. A. et al., "Comparison of midazolam by mouth and diazepam IV in outpatient oral surgery," Br J. Anaesth, 59:746-754 (1987)
Hargreaves, J., "Benzodiazepine premedication in minor day-case surgery: comparison of oral midazolam and temazepam with placebo," Br J. Anaesth, 61:611-616 (1988)
Clausen, T. G., et al., "Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration," Br J. Clin. Pharmacol, 25:457-463 (1988)
Wilton, N. C. T. et al., "Preanesthetic sedation of preschool children using intranasal midazolam," Anesthesiology, 69:972-975 (1988)
Noyes, R. et al., "Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. II. Patient acceptance, side effects, and safety," Arch Gen Psychiatry, 45:423-428 (1988)
Greenblatt, D. J. et al., "Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo," Clin. Pharmacol Ther, 45:356-365 (1989)
Sostmann, H. J. et al., "Dose equivalence of midazolam and triazolam," Eur J. Clin Pharmacol, 36:181-187 (1989)
Forster A., "Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone-a double-blind randomized study", Anesth Analg, 62:920-924 (1983)
Curtis, L. D. et al., "Arterial oxygen desaturation following intravenous injection of midazolam," J Amer Assoc of Nurse Anesth, 57:244-249 (1989)
Rickels, K. et al., "Long-term diazepam therapy and clinical outcome," JAMA, 250:767-771 (1983)
Rickels, K. et al., "Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone," Arch Gen Psychiatry, 45:444-450 (1988)
Allen, R. P. et al., "Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months," J Clin Pharmacol, 25:457-463 (1987)
Koopmans, R. et al., "Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system," Clin Pharmacol Ther, 44:14-22 (1988)
Schweizer, E. et al., "Lorazepam vs. alprazolam in the treatment of panic disorder," Pharmacopsychiatry, 23:90-93 (1990)
de Wit, H. et al., "Lack of preference for diazepam in anxious volunteers," Arch Gen Psychiatry, 43:533-541 (1986)
Ciraulo, D. A. et al., "Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study," Am J Psychiatry, 146:1333-1335 (1989
December 13, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
